Literature DB >> 22341426

Does donor arterial partial pressure of oxygen affect outcomes after lung transplantation? A review of more than 12,000 lung transplants.

Farhan Zafar1, Muhammad S Khan, Jeffrey S Heinle, Iki Adachi, E Dean McKenzie, Marc G Schecter, George B Mallory, David L S Morales.   

Abstract

INTRODUCTION: In lung transplantation (LTx), the arterial partial pressure of oxygen (PaO(2)) is traditionally regarded as critical information for assessment of donor lung function. Each center sets its own thresholds; by convention, a donor PaO(2) of less than 300 mm Hg has been considered disqualifying. Limited literature exists to support such a practice. We analyzed all LTxs performed in the United States over a 9-year period to assess the effect of donor PaO(2) on graft survival.
METHODS: The United Network for Organ Sharing (UNOS) database was queried for LTx (January 2000-November 2009). Of 12,545 LTx performed, 12,045 (96%) had donor PaO(2) data on a fraction of inspired oxygen of 1.0, recorded at the time of procurement.
RESULTS: Mean donor PaO(2) was 407 ± 140 mm Hg. The majority of LTxs had a donor PaO(2) greater than 300 mm Hg (9593 (80%]) whereas PaO(2) was 200 mm Hg or less in 1830 (15%) and 201 to 300 in 582 (5%) donors. Use of donors with a PaO(2) of less than 200 increased over time from 5% (45) in 2000 to 21% (295) in 2009 (P = .002). Kaplan-Meier survival analysis showed no difference in graft survival with differing donor PaO(2)s, irrespective of whether patients had a single or double LTx. A Cox multivariable analysis of 21 donor characteristics demonstrated that donor PaO(2) had no association with graft survival.
CONCLUSIONS: Donor PaO(2) levels did not affect graft survival. The use of donors with lower PaO(2)s could substantially increase the donor pool. We are not suggesting that donor PaO(2) is not important when assessing potential lung donors but its level of importance in regard to other criteria appears less than previously believed. Copyright Â
© 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341426     DOI: 10.1016/j.jtcvs.2012.01.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Impact of Donor Arterial Partial Pressure of Oxygen on Outcomes After Lung Transplantation in Adult Cystic Fibrosis Recipients.

Authors:  Don Hayes; Benjamin T Kopp; Stephen E Kirkby; Susan D Reynolds; Heidi M Mansour; Joseph D Tobias; Dmitry Tumin
Journal:  Lung       Date:  2016-06-08       Impact factor: 2.584

Review 2.  Evaluation and Management of the Potential Lung Donor.

Authors:  Andrew Courtwright; Edward Cantu
Journal:  Clin Chest Med       Date:  2017-08-31       Impact factor: 2.878

Review 3.  Lung donor selection criteria.

Authors:  John Chaney; Yoshikazu Suzuki; Edward Cantu; Victor van Berkel
Journal:  J Thorac Dis       Date:  2014-08       Impact factor: 2.895

4.  A new lung donor score to predict short and long-term survival in lung transplantation.

Authors:  Jonas P Ehrsam; Ulrike Held; Isabelle Opitz; Ilhan Inci
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

Review 5.  Medical Management of Brain-Dead Organ Donors.

Authors:  A S M Tanim Anwar; Jae-Myeong Lee
Journal:  Acute Crit Care       Date:  2019-02-28

Review 6.  Advanced considerations in organ donors.

Authors:  Hailey M Shepherd; Jason M Gauthier; Varun Puri; Daniel Kreisel; Ruben G Nava
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

7.  Donor selection for lung transplant in Turkey: Is it necessary to wait for an ideal donor?

Authors:  Mustafa Vayvada; Ahmet Erdal Taşçı
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-07-26       Impact factor: 0.332

8.  Aggressive pursuit and utilization of non-ideal donor lungs does not compromise post-lung transplant survival.

Authors:  Samantha E Halpern; Oliver K Jawitz; Vignesh Raman; Ashley Y Choi; John C Haney; Jacob A Klapper; Matthew G Hartwig
Journal:  Clin Transplant       Date:  2021-07-14       Impact factor: 3.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.